Probiotics combined with rifaximin influence the neurometabolic changes in a rat model of type C HE

Abstract Type C hepatic encephalopathy (HE) is a neuropsychiatric disease caused by chronic liver disease. Management of type C HE remains an important challenge because treatment options are limited. Both the antibiotic rifaximin and probiotics have been reported to reduce the symptoms of HE, but l...

Full description

Bibliographic Details
Main Authors: Emmanuelle Flatt, Valérie A. McLin, Olivier Braissant, Katarzyna Pierzchala, Paola Mastromarino, Stefanita-Octavian Mitrea, Dario Sessa, Rolf Gruetter, Cristina Cudalbu
Format: Article
Language:English
Published: Nature Publishing Group 2021-09-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-97018-8